- The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). Urology. 2017 In Process GET IT
- An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 In Process GET IT
- Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. European Urology. 2016 In Process GET IT
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
Nature reviews. Urology.
Times cited: 9
Challenges and recommendations for early identification of metastatic disease in prostate cancer.
Times cited: 22
Testosterone in prostate cancer: the Bethesda consensus.
Times cited: 11
The effect of digital rectal examination on prostate-specific antigen levels.
Journal of the American Medical Association.
Times cited: 75